Alberto Castro

•Cardiology Research Fellow-Harvard/BIDMC | •MD Universidad Autónoma de Guadalajara | •Director of the WikiDoc Scholar Progam

[C. Michael Gibson MD @CMichaelGibson]

20 years ago over New Years, I founded https://t.co/651gAsLxGX , a free, copyleft, open access textbook of medicine.

Thousands of doctors have edited it millions of times.

It is viewed over a billion times per year.

Send an email to [email protected] to become an editor and help keep our content up to date and earn academic credit !

[Cardiology Now News @CardioNowNews]

Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

Written by @acastrom91

Summary, analysis and more #AHA2025 coverage below! https://t.co/KDRthYcgd6

@CMichaelGibson @ceciliabahit
#Cardiology #HeartFailure #Medicine #diabetes #tirzepatide

[Alberto Castro @acastrom91]

Another @wikidoc meeting where the dissemination of medical knowledge and global collaboration come together to build a true academic community. Honored to be part of a project founded by my mentor Dr. @CMichaelGibson that continues to impact medical education worldwide #MedEd

[Cardiology Now News @CardioNowNews]

Health360xai Successfully Implemented Decentralized Clinical Trials in Underserved Populations

Written by @acastrom91!

Summary, analysis and more #ACC25 coverage below! https://t.co/WrxDGfpq93

@CMichaelGibson @ceciliabahit

[Internal Medicine Interest Group - Journal Club @IMIGJOURNALCLUB]

As co-founders of the Internal Medicine Interest Group (IMIG), we are proud to present a platform dedicated to discussion, engagement, and enrichment of those who wish to be part of it.

[Cardiology Now News @CardioNowNews]

Improved Accuracy of HF Diagnosis with HFDetect-AI

Written by @acastrom91!

Summary, analysis and more #ESCCongress coverage below! https://t.co/ehGXoNt1hi

@CMichaelGibson

[Cardiology Now News @CardioNowNews]

Pre-Hospital Pulse-Dose Glucocorticoid Did not Reduce Infarct Size in STEMI: PULSE-MI

Written by @acastrom91!

Summary, analysis and more #ESCCongress coverage below! https://t.co/naCmVxB7NO

@CMichaelGibson

[Cardiology Now News @CardioNowNews]

SWEDEGRAFT Trial: No Advantage of No-Touch vs Conventional Vein Harvesting in Coronary Artery Bypass Surgery

Written by @acastrom91!

Summary, analysis and more #ESCCongress coverage below! https://t.co/djJM0VgnwD

@CMichaelGibson

[JACC Journals @JACCJournals]

#ACC24 #JACC LBCT SimPub: #AEGIS-II trial shows numerically lower rates of CV death & #cvMI, type-1 MI, & stent thrombosis-related MI compared to placebo suggesting a role of apoA-I in ⬇️ subsequent plaque disruption events via enhanced cholesterol efflux https://t.co/vzDitE7P8V

[Cardiology Now News @CardioNowNews]

IVUS -DBC: IVUS-guided drug-coated balloon angioplasty improves primary patency

Written by @acastrom91 !

Summary, analysis and more #ACC24 coverage below!
https://t.co/8lFRnS8R8L

@CMichaelGibson

[Cardiology Now News @CardioNowNews]

IVUS-Guided DES Reduced MACE at 1 year Compared to Angiography-Guided PCI: IVUS-ACS Trial

Written by @acastrom91!

Summary, analysis and more #ACC24 coverage below! https://t.co/C6wznZevdY

@CMichaelGibson

[C. Michael Gibson MD @CMichaelGibson]

AEGIS-II trial shows in AMI pts with multivessel disease + additional CV risk factors and on GDMT, 4 weekly infusions of CSL112 did not reduce primary endpoint of CV death, MI, or stroke thru 90 days. Additional analysis shows CV outcome benefits statistically significant in pts with baseline high LDL > 100 mg/dl.

[ACC Media Center @ACCmediacenter]

If your LDL is low & you don’t have a lot of lipid in your plaque then delipidation is not going to help. If you have high LDL, you have more lipid in your plaque and should have the garbage trucks take the garbage out, summarizes Dr. @CMichaelGibson on the AEGIS-II trial. #ACC24

[C. Michael Gibson MD @CMichaelGibson]

In todays Wall Street Journal I talk about how new anticoagulant drugs called Factor XI inhibitors could reduce the higher risk of bleeding:
“Too low of a dose, you clot; too high of a dose, you bleed. Our goal is to keep people from falling off the balance beam.”
https://t.co/c8ZY8lByu5 via @WSJ

[Cardiology Now News @CardioNowNews]

Recaticimab Effective as Add-On Therapy in Non-Familial Hypercholesterolaemia and Mixed Hyperlipidemia: REMAIN-2 Trial 

Written by @acastrom91!

Summary and analysis and more #AHA23 coverage below! https://t.co/x3jnwCRR4X

@CMichaelGibson

[Cardiology Now News @CardioNowNews]

Lowering blood pressure significantly reduced dementia risk in people with hypertension in rural China
Written by @acastrom91!

Summary and analysis and more #AHA23 coverage below! https://t.co/xtvrDDnIza

@CMichaelGibson

[C. Michael Gibson MD @CMichaelGibson]

RIGHT trial: Routine post-procedural anticoagulation after primary PCI in STEMI fails to improve ischemic outcomes at 30 days #ESCCongress

[Cardiology Now News @CardioNowNews]

DICTATE-AHF Trial: Early Dapagliflozin in AHF does not meet primary endpoint of diuretic efficiency

Written by @acastrom91

Summary and analysis and more #ESCCongress coverage below!

https://t.co/LKLS1C9Q7w

@CMichaelGibson

[Cardiology Now News @CardioNowNews]

RIGHT Trial: Anticoagulation shows no benefit after primary PCI in STEMI

Written by @acastrom91

Summary and analysis and more #ESCCongress coverage below! https://t.co/ysLtCZpaIC
@CMichaelGibson

[Cardiology Now News @CardioNowNews]

FIRE: Complete revascularization better than culprit-only strategy for elderly with MI and MVD

Written by Alberto Castro! Summary and analysis and more #ESCCongress coverage below!
https://t.co/4O4oqpPBks

@CMichaelGibson